METTL14 promotes lipid metabolism reprogramming and sustains nasopharyngeal carcinoma progression via enhancing m6A modification of ANKRD22 mRNA.

Autor: Li, Lvyuan1,2 (AUTHOR), Tang, Qiling1,2 (AUTHOR), Ge, Junshang2 (AUTHOR), Wang, Dan2 (AUTHOR), Mo, Yongzhen2,3 (AUTHOR), Zhang, Yijie1,2 (AUTHOR), Wang, Yumin2,3 (AUTHOR), Xiong, Fang2,3 (AUTHOR), Yan, Qijia2,3 (AUTHOR), Liao, Qianjin1 (AUTHOR), Guo, Can2 (AUTHOR), Wang, Fuyan2 (AUTHOR), Zhou, Ming2 (AUTHOR), Xiang, Bo2 (AUTHOR), Zeng, Zhaoyang1,2 (AUTHOR), Shi, Lei1,4 (AUTHOR) shilei81@csu.edu.cn, Chen, Pan1 (AUTHOR) chenpan08@csu.edu.cn, Xiong, Wei1,2 (AUTHOR) xiongwei@csu.edu.cn
Zdroj: Clinical & Translational Medicine. Jul2024, Vol. 14 Issue 7, p1-25. 25p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje